Pavan Cheruvu
Amministratore Delegato presso Bitterroot Bio, Inc.
Profilo
Pavan Cheruvu is currently the Chief Executive Officer at Bitterroot Bio, Inc. Prior to his current position, he served as the Chief Executive Officer at Sio Gene Therapies, Inc. from 2018 to 2022 and at Axovant Sciences, Inc. from 2018 to 2020.
Dr. Cheruvu obtained his undergraduate degree from Duke University, his graduate degree from the University of Oxford, and his doctorate from Harvard Medical School.
Posizioni attive di Pavan Cheruvu
| Società | Posizione | Inizio |
|---|---|---|
Bitterroot Bio, Inc.
 Bitterroot Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Bitterroot Bio, Inc. is a pioneer in the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health. The company is based in Palo Alto, CA. The company's research discoveries have uncovered critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease. The CEO of the company is Pavan Cheruvu. | Amministratore Delegato | - |
Precedenti posizioni note di Pavan Cheruvu
| Società | Posizione | Fine |
|---|---|---|
| SIO GENE THERAPIES INC. | Amministratore Delegato | 31/01/2022 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Amministratore Delegato | 01/12/2020 |
Formazione di Pavan Cheruvu
| Duke University | Undergraduate Degree |
| University of Oxford | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Bitterroot Bio, Inc. is a pioneer in the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health. The company is based in Palo Alto, CA. The company's research discoveries have uncovered critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease. The CEO of the company is Pavan Cheruvu. | Commercial Services |
- Borsa valori
- Insiders
- Pavan Cheruvu
